ENANTA PHARMACEUTICALS, INC Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
ENANTA PHARMACEUTICALS, INC (ENTA) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $31.00 thousand for the 12-month period ending 2015-09-30, per its 10-K filed 2015-12-11.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2015-12-11
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2013-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2012-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2015 was $31.00K, a 933.33% increase from fiscal 2014.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2014 was $3.00K, a 97.00% decline from fiscal 2013.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2013 was $100.00K, a 58.73% increase from fiscal 2012.
- ENANTA PHARMACEUTICALS, INC gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2012 was $63.00K, a 800.00% increase from fiscal 2011.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|
| 2015-09-30 | $31.00K 10-K · filed 2015-12-11 | ||
| 2014-09-30 | $3.00K 10-K · filed 2015-12-11 | ||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $100.00K 10-K · filed 2015-12-11 | |
| 2013-06-30 | $100.00K 10-Q · filed 2014-08-12 | ||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $63.00K 10-K · filed 2014-12-11 | |
| 2012-06-30 | $63.00K 10-Q · filed 2013-08-12 | ||
| 2011-09-30 | $7.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |